Abeona Therapeutics (ABEO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Abeona Therapeutics (ABEO) is Neutral.

The composite score behind that read is -0.13, weighing +0.02 of bullish evidence against -0.28 bearish.

Abeona Therapeutics last closed at $4.94, -0.40% on the session.

Against the IVW growth benchmark the position is -1.20% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

17 graded predictions for ABEO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Abeona Therapeutics in the 20th percentile on return on equity, where 100 is best.

Abeona Therapeutics is classified under Health Care / Biotechnology, with a market capitalisation of $283.63M.

StockMap tracks Abeona Therapeutics as the 214th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Abeona Therapeutics ranks 237th of 381 in the group, against a group median of -0.08.